Sinopharm H1 Revenue RMB 26.73 Billion, Net Profit RMB 880 Million, Down 7.25%

Sinopharm Co. , Ltd. released its 2026 semi-annual report. In the first half, the company achieved total operating revenue of RMB 26.728 billion, up 4.27% year-on-year; net profit attributable to shareholders of the parent company was RMB 880 million, down 7.25% year-on-year; basic earnings per share was RMB 1.166, down 7.25% year-on-year.

In the second quarter, the company achieved total operating revenue of RMB 13.173 billion, up 1.95% year-on-year; net profit attributable to shareholders of the parent company was RMB 406 million, down 17.16% year-on-year.